Correlation Between Nuvalent and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Nuvalent and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Zentalis Pharmaceuticals.
Diversification Opportunities for Nuvalent and Zentalis Pharmaceuticals
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvalent and Zentalis is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Nuvalent i.e., Nuvalent and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvalent and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Nuvalent is expected to generate 0.5 times more return on investment than Zentalis Pharmaceuticals. However, Nuvalent is 2.0 times less risky than Zentalis Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.09 per unit of risk. If you would invest 8,661 in Nuvalent on October 22, 2024 and sell it today you would lose (1,077) from holding Nuvalent or give up 12.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Nuvalent vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
Nuvalent |
Zentalis Pharmaceuticals |
Nuvalent and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvalent and Zentalis Pharmaceuticals
The main advantage of trading using opposite Nuvalent and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |